As of Apr 20
| -0.20 / -1.20%|
The 3 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 22.00, with a high estimate of 25.00 and a low estimate of 20.00. The median estimate represents a +33.33% increase from the last price of 16.50.
The current consensus among 3 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.